{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:32:54Z","timestamp":1789813974668,"version":"4.0.1"},"reference-count":94,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["2104"],"award-info":[{"award-number":["2104"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 5119A2\/1"],"award-info":[{"award-number":["RG 5119A2\/1"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2015.00544","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T10:35:05Z","timestamp":1446028505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["The Role of Latently Infected B Cells in CNS Autoimmunity"],"prefix":"10.3389","volume":"6","author":[{"given":"Ana Citlali","family":"M\u00e1rquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Steven","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1182\/blood-2003-11-4025","article-title":"High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay","volume":"103","author":"Crawford","year":"2004","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-immunol-032713-120227","article-title":"Immunology of relapse and remission in multiple sclerosis","volume":"32","author":"Steinman","year":"2014","journal-title":"Ann Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/WCO.0b013e32815610c2","article-title":"Multiple sclerosis: the environment and causation","volume":"20","author":"Giovannoni","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2012.01134.x","article-title":"The genetics of multiple sclerosis: an up-to-date review","volume":"248","author":"Gourraud","year":"2012","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1172\/jci63842","article-title":"B cell exchange across the blood-brain barrier in multiple sclerosis","volume":"122","author":"von Budingen","year":"2012","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/aje\/154.1.69","article-title":"Cigarette smoking and incidence of multiple sclerosis","volume":"154","author":"Hernan","year":"2001","journal-title":"Am J Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0140-6736(81)91527-0","article-title":"Multiple sclerosis and Epstein-Barr virus","volume":"2","author":"Warner","year":"1981","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1128\/jvi.00445-07","article-title":"Epstein-Barr virus entry","volume":"81","author":"Hutt-Fletcher","year":"2007","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","article-title":"On the dynamics of acute EBV infection and the pathogenesis of infectious","volume":"111","author":"Hadinoto","year":"2008","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18093","DOI":"10.1073\/pnas.0509311102","article-title":"Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells","volume":"102","author":"Souza","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-Barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"issue":"11","key":"B16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrneurol.2012.198","article-title":"The initiation and prevention of multiple sclerosis","volume":"8","author":"Ascherio","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/archneur.64.1.72","article-title":"Multiple sclerosis after infectious mononucleosis","volume":"64","author":"Nielsen","year":"2007","journal-title":"Arch Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000201564","article-title":"Association of infectious mononucleosis with multiple sclerosis. A population-based study","volume":"32","author":"Ramagopalan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2014.04.005","article-title":"Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1","volume":"272","author":"Ruprecht","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1468-1331.2010.03005.x","article-title":"Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis","volume":"17","author":"Lindsey","year":"2010","journal-title":"Eur J Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/WNL.35.3.435","article-title":"Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis","volume":"35","author":"Larsen","year":"1985","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1172\/jci23661","article-title":"Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis","volume":"115","author":"Cepok","year":"2005","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze","year":"2006","journal-title":"Arch Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni835","article-title":"A functional and structural basis for TCR cross-reactivity in multiple sclerosis","volume":"3","author":"Lang","year":"2002","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0165-5728(96)00069-0","article-title":"An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway","volume":"69","author":"Vaughan","year":"1996","journal-title":"J Neuroimmunol"},{"key":"B29","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.163.7.4027","article-title":"Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients","volume":"163","author":"Esposito","year":"1999","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","article-title":"Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis","volume":"74","author":"Sargsyan","year":"2010","journal-title":"Neurology"},{"key":"B33","first-page":"409","article-title":"Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis","volume":"38","author":"Prineas","year":"1978","journal-title":"Lab Invest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"issue":"Pt 5","key":"B35","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1093\/brain\/awp296","article-title":"Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"133","author":"Peferoen","year":"2010","journal-title":"Brain"},{"key":"B36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0165-5728(00)00181-8","article-title":"Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis","volume":"105","author":"van Noort","year":"2000","journal-title":"J Neuroimmunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"Pender","year":"2003","journal-title":"Trends Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/0008-5472.can-11-3399","article-title":"Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy","volume":"72","author":"Smith","year":"2012","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1177\/1352458514521888","article-title":"Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis","volume":"20","author":"Pender","year":"2014","journal-title":"Mult Scler"},{"key":"B40","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.4049\/jimmunol.163.9.5133","article-title":"B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions","volume":"163","author":"Baranzini","year":"1999","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1172\/jci3568","article-title":"Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis","volume":"102","author":"Qin","year":"1998","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.4049\/jimmunol.171.5.2725","article-title":"Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid","volume":"171","author":"Owens","year":"2003","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jaut.2011.08.003","article-title":"B cells undergo unique compartmentalized redistribution in multiple sclerosis","volume":"37","author":"Haas","year":"2011","journal-title":"J Autoimmun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.1073\/pnas.0402455101","article-title":"Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis","volume":"101","author":"Corcione","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/s0140-6736(11)61649-8","article-title":"Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial","volume":"378","author":"Kappos","year":"2011","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/wnl.0000000000000125","article-title":"Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study","volume":"82","author":"Sorensen","year":"2014","journal-title":"Neurology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1084\/jem.167.2.332","article-title":"The essential role of B cell stimulatory factor 2 (BSF-2\/IL-6) for the terminal differentiation of B cells","volume":"167","author":"Muraguchi","year":"1988","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/eji.201344007","article-title":"B-cell modulation of dendritic-cell function: signals from the far side","volume":"44","author":"Zietara","year":"2014","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.2569","article-title":"Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells","volume":"14","author":"Bermejo","year":"2013","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/jci15770","article-title":"IFNs and STATs in innate immunity to microorganisms","volume":"109","author":"Decker","year":"2002","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/B978-0-12-387663-8.00001-6","article-title":"Modeling a complex disease: multiple sclerosis","volume":"110","author":"Kurschus","year":"2011","journal-title":"Adv Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1002\/(SICI)1521-4141(199911)29:113432::AID-IMMU34323.0.CO;2-2","article-title":"B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide","volume":"29","author":"Lyons","year":"1999","journal-title":"Eur J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann Neurol"},{"issue":"13","key":"B58","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1084\/jem.20042321","article-title":"Impaired early B cell tolerance in patients with rheumatoid arthritis","volume":"201","author":"Samuels","year":"2005","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1172\/jci68775","article-title":"Specific peripheral B cell tolerance defects in patients with multiple sclerosis","volume":"123","author":"Kinnunen","year":"2013","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","article-title":"Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission","volume":"239","author":"Knippenberg","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B65","first-page":"44","article-title":"Murine gammaherpesvirus 68: a model for the study of Epstein-Barr virus infections and related diseases","volume":"57","author":"Olivadoti","year":"2007","journal-title":"Comp Med"},{"key":"B66","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1128\/JVI.71.8.5894-5904.1997","article-title":"Complete sequence and genomic analysis of murine gammaherpesvirus 68","volume":"71","author":"Virgin","year":"1997","journal-title":"J Virol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1128\/JVI.77.15.8310-8321.2003","article-title":"Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo","volume":"77","author":"Willer","year":"2003","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1098\/rstb.2000.0779","article-title":"Natural history of murine gamma-herpesvirus infection","volume":"356","author":"Nash","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.170.7.3828","article-title":"Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice","volume":"170","author":"Flano","year":"2003","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1000677","DOI":"10.1371\/journal.ppat.1000677","article-title":"Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes","volume":"5","author":"Liang","year":"2009","journal-title":"PLoS Pathog"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1000039","DOI":"10.1371\/journal.ppat.1000039","article-title":"The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation","volume":"4","author":"Siegel","year":"2008","journal-title":"PLoS Pathog"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1128\/jvi.01953-12","article-title":"The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells","volume":"87","author":"Krug","year":"2013","journal-title":"J Virol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","article-title":"Identification of virus-encoded microRNAs","volume":"304","author":"Pfeffer","year":"2004","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nmeth746","article-title":"Identification of microRNAs of the herpesvirus family","volume":"2","author":"Pfeffer","year":"2005","journal-title":"Nat Methods"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e981","DOI":"10.1128\/mBio.00981-14","article-title":"Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo","volume":"5","author":"Feldman","year":"2014","journal-title":"MBio"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.4049\/jimmunol.1003495","article-title":"Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN","volume":"187","author":"Jarousse","year":"2011","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"14149","DOI":"10.1128\/jvi.79.22.14149-14160.2005","article-title":"Alpha\/beta interferons regulate murine gammaherpesvirus latent gene expression","volume":"79","author":"Barton","year":"2005","journal-title":"J Virol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1128\/jvi.06829-11","article-title":"Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells","volume":"86","author":"Salamon","year":"2012","journal-title":"J Virol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"9163","DOI":"10.1074\/jbc.M511884200","article-title":"The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production","volume":"281","author":"Xu","year":"2006","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1074\/jbc.273.14.8003","article-title":"Differences in activity between alpha and beta type I interferons explored by mutational analysis","volume":"273","author":"Runkel","year":"1998","journal-title":"J Biol Chem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/eji.200323148","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68","volume":"33","author":"Peacock","year":"2003","journal-title":"Eur J Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/08916934.2013.785535","article-title":"Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68","volume":"46","author":"Chauhan","year":"2013","journal-title":"Autoimmunity"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e1002715","DOI":"10.1371\/journal.ppat.1002715","article-title":"Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis","volume":"8","author":"Casiraghi","year":"2012","journal-title":"PLoS Pathog"},{"key":"B84","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1038\/srep13995","article-title":"Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis","volume":"5","author":"Casiraghi","year":"2015","journal-title":"Sci Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/thy.1999.9.749","article-title":"CD40 expression in human thyroid tissue: evidence for involvement of multiple","volume":"9","author":"Smith","year":"1999","journal-title":"Thyroid"},{"key":"B86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2337\/diabetes.55.01.06.db04-1154","article-title":"Costimulation blockade of both inducible costimulator and CD40 ligand induces","volume":"55","author":"Nanji","year":"2006","journal-title":"Diabetes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"J Neurosci Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e21386","DOI":"10.1371\/journal.pone.0021386","article-title":"T regulatory cells are markers of disease activity in multiple sclerosis patients","volume":"6","author":"Dalla Libera","year":"2011","journal-title":"PLoS One"},{"key":"B89","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/NEN.0b013e3182622691","article-title":"B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model","volume":"71","author":"Jagessar","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11481-012-9384-x","article-title":"Antibodies against human BLyS and APRIL attenuate EAE development in marmoset monkeys","volume":"7","author":"Jagessar","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s11481-013-9448-6","article-title":"The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of gamma-herpesvirus infected B cells in the marmoset EAE model","volume":"8","author":"Anwar Jagessar","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ana.22449","article-title":"Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate","volume":"70","author":"Axthelm","year":"2011","journal-title":"Ann Neurol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/s0002-9440(10)63726-1","article-title":"Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions","volume":"164","author":"Mason","year":"2004","journal-title":"Am J Pathol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-60761-720-4_20","article-title":"Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model","volume":"900","author":"Acs","year":"2014","journal-title":"Methods Mol Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T17:16:20Z","timestamp":1692119780000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2015.00544\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,28]]},"references-count":94,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2015.00544","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,28]]}}}